T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$715M |
| 2 |
Linde
LIN
|
+$549M |
| 3 |
Xcel Energy
XEL
|
+$547M |
| 4 |
Intercontinental Exchange
ICE
|
+$533M |
| 5 |
AbbVie
ABBV
|
+$503M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$948M |
| 2 |
TE Connectivity
TEL
|
+$756M |
| 3 |
Yum! Brands
YUM
|
+$685M |
| 4 |
Becton Dickinson
BDX
|
+$666M |
| 5 |
Ingersoll Rand
IR
|
+$648M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 22.34% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 11.89% |
| 5 | Consumer Discretionary | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
O'Reilly Automotive
ORLY
$75.2B
| $510M | 0.39% |
9,060,330
-1,523,715
| -14% | -$81.9M |
|
77
Verisk Analytics
VRSK
$23.6B
| $499M | 0.38% |
2,827,459
+2,364
| +0.1% | +$415K |
|
78
Five Below
FIVE
$13.5B
| $483M | 0.37% |
2,730,378
+259,012
| +10% | +$40.7M |
|
79
Tradeweb Markets
TW
$22.1B
| $475M | 0.36% |
7,322,321
+4,873
| +0.1% | +$286K |
|
80
argenx
ARGX
$54.5B
| $465M | 0.36% |
1,226,867
-791,351
| -39% | -$296M |
|
|
HZNP
81
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $461M | 0.35% |
+4,050,259
| New | +$336M |
|
82
IDEX
IEX
$17.5B
| $461M | 0.35% |
2,018,566
+440
| +0% | +$98.3K |
|
83
Visa
V
$674B
| $453M | 0.35% |
2,180,527
-164,314
| -7% | -$33.1M |
|
84
Eli Lilly
LLY
$1.09T
| $446M | 0.34% |
+1,218,959
| New | +$432M |
|
85
PTC
PTC
$16B
| $443M | 0.34% |
3,691,102
+4,760
| +0.1% | +$569K |
|
86
Ionis Pharmaceuticals
IONS
$9.39B
| $441M | 0.34% |
11,678,259
+521,564
| +5% | +$21.9M |
|
87
Alcon
ALC
$35.3B
| $436M | 0.33% |
6,364,199
+13,120
| +0.2% | +$837K |
|
88
NVIDIA
NVDA
$5.48T
| $435M | 0.33% |
29,773,140
+6,888,860
| +30% | +$101M |
|
89
RPM International
RPM
$14.5B
| $430M | 0.33% |
4,414,175
-1,024,663
| -19% | -$99.4M |
|
90
Amphenol
APH
$207B
| $420M | 0.32% |
11,037,056
+5,984
| +0.1% | +$226K |
|
91
Exelon
EXC
$47B
| $413M | 0.32% |
+9,559,548
| New | +$378M |
|
92
Boston Beer
SAM
$1.93B
| $408M | 0.31% |
1,239,545
-132,519
| -10% | -$48.1M |
|
93
West Pharmaceutical
WST
$24.4B
| $405M | 0.31% |
1,719,972
+12,228
| +0.7% | +$2.9M |
|
94
ESAB
ESAB
$5.23B
| $400M | 0.31% |
8,517,838
+1,920,386
| +29% | +$80.4M |
|
95
CrowdStrike
CRWD
$230B
| $396M | 0.3% |
15,044,856
+5,763,620
| +62% | +$197M |
|
96
ICU Medical
ICUI
$4.48B
| $382M | 0.29% |
2,423,228
-55,633
| -2% | -$8.47M |
|
97
GE HealthCare
GEHC
$33B
| $378M | 0.29% |
+6,480,940
| New | +$373M |
|
98
Magnolia Oil & Gas
MGY
$6.13B
| $369M | 0.28% |
15,720,703
+55,508
| +0.4% | +$1.35M |
|
99
Starbucks
SBUX
$125B
| $367M | 0.28% |
3,699,200
-2,373,024
| -39% | -$224M |
|
100
Cheniere Energy
LNG
$55.3B
| $364M | 0.28% |
2,427,260
-599,269
| -20% | -$100M |
|
Similar funds
T. Rowe Price Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Investment Management held 577 positions worth $130B, up 4.1% from $125B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Investment Management's Q4 2022 filing shows 38 new, 261 increased, 232 reduced and 36 closed positions. Its largest new stake was Xcel Energy: 8,228,100 shares worth $577M. The largest sale was Alphabet (Google) Class C, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q4 2022 buy was Xcel Energy: 8,228,100 shares worth $577M.
- T. Rowe Price Investment Management added most to Equifax in Q4 2022, an estimated $715M increase.
- T. Rowe Price Investment Management's biggest Q4 2022 reduction was TE Connectivity, cutting an estimated $756M.
- T. Rowe Price Investment Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $948M.
- T. Rowe Price Investment Management's ten largest holdings make up 16% of its $130B portfolio in Q4 2022.
- T. Rowe Price Investment Management opened 38 new positions and closed 36 in Q4 2022.
- T. Rowe Price Investment Management's portfolio value rose 4.1% quarter-over-quarter to $130B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.